DK0561927T3 - Farmaceutiske præparater til behandling af maligne B-celle-affektioner - Google Patents

Farmaceutiske præparater til behandling af maligne B-celle-affektioner

Info

Publication number
DK0561927T3
DK0561927T3 DK92901009.8T DK92901009T DK0561927T3 DK 0561927 T3 DK0561927 T3 DK 0561927T3 DK 92901009 T DK92901009 T DK 92901009T DK 0561927 T3 DK0561927 T3 DK 0561927T3
Authority
DK
Denmark
Prior art keywords
malignant
pharmaceuticals
treatment
cell
cell malignancies
Prior art date
Application number
DK92901009.8T
Other languages
Danish (da)
English (en)
Inventor
Jacques Banchereau
France Thierry De
Original Assignee
Schering Plough Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Plough Corp filed Critical Schering Plough Corp
Application granted granted Critical
Publication of DK0561927T3 publication Critical patent/DK0561927T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/20Interleukins [IL]
    • A61K38/2026IL-4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
DK92901009.8T 1990-12-13 1991-12-10 Farmaceutiske præparater til behandling af maligne B-celle-affektioner DK0561927T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP90403585A EP0490006B1 (en) 1990-12-13 1990-12-13 Pharmaceutical compositions for the treatment of B-cell malignancies

Publications (1)

Publication Number Publication Date
DK0561927T3 true DK0561927T3 (da) 1996-07-29

Family

ID=8205785

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92901009.8T DK0561927T3 (da) 1990-12-13 1991-12-10 Farmaceutiske præparater til behandling af maligne B-celle-affektioner

Country Status (16)

Country Link
EP (2) EP0490006B1 (cs)
JP (1) JPH06504767A (cs)
AT (1) ATE135232T1 (cs)
AU (1) AU9072191A (cs)
CA (1) CA2098509A1 (cs)
CZ (1) CZ113593A3 (cs)
DE (1) DE69117974T2 (cs)
DK (1) DK0561927T3 (cs)
ES (1) ES2084995T3 (cs)
FI (1) FI932650A0 (cs)
GR (1) GR3019699T3 (cs)
HU (1) HU210009B (cs)
IE (1) IE64157B1 (cs)
OA (1) OA09788A (cs)
SK (1) SK59193A3 (cs)
WO (1) WO1992010201A1 (cs)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994004179A1 (en) * 1992-08-19 1994-03-03 Schering Corporation Method for inhibiting hiv replication using il-4
US5679338A (en) * 1994-05-12 1997-10-21 Osteoarthritis Science, Inc. Use of IL-4 for inhibition of the breakdown of articular cartilage and other tissues
US5716612A (en) * 1994-09-07 1998-02-10 Schering Corporation Use of IL-4 for potentiation of chemotherapeutic agents

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0552243T3 (da) * 1990-09-06 1997-03-10 Schering Corp Anvendelse af interleukin-4 til behandling af faste tumorer

Also Published As

Publication number Publication date
AU9072191A (en) 1992-07-08
HUT64478A (en) 1994-01-28
HU210009B (en) 1995-01-30
ATE135232T1 (de) 1996-03-15
DE69117974D1 (de) 1996-04-18
CA2098509A1 (en) 1992-06-14
FI932650A (fi) 1993-06-10
EP0561927A1 (en) 1993-09-29
SK59193A3 (en) 1994-01-12
EP0490006A1 (en) 1992-06-17
IE914328A1 (en) 1992-06-17
GR3019699T3 (en) 1996-07-31
EP0490006B1 (en) 1994-06-22
HU9301719D0 (en) 1993-09-28
JPH06504767A (ja) 1994-06-02
WO1992010201A1 (en) 1992-06-25
ES2084995T3 (es) 1996-05-16
FI932650A0 (fi) 1993-06-10
OA09788A (en) 1994-04-15
DE69117974T2 (de) 1996-07-25
IE64157B1 (en) 1995-07-12
EP0561927B1 (en) 1996-03-13
CZ113593A3 (en) 1994-01-19

Similar Documents

Publication Publication Date Title
SE8503680L (sv) Indolderivat
PT723538E (pt) Compostos triciclicos de carbamato uteis para a ainibicao da funcao da proteina g e para o tratamento de doencas proliferativas
DK518683D0 (da) Fremgangsmade til fremstilling af 4"epi-9-deoxo-9a-methyl-9a-aza-9a-homoerythromycin a eller farmaceutisk acceptable syreadditionssalte deraf og mellemprodukter ved fremgangsmaden
ES2051641A1 (es) Procedimientos para la preparacion de compuestos derivados de tiourea.
EA200100623A1 (ru) Кетолидные антибиотики
PA8486401A1 (es) Antibioticos cetolidos carbamato y carbazato
GR3017128T3 (en) Treatment of hiv infections and compounds useful therein.
ATE215952T1 (de) Hiv-proteaseinhibitoren
DE69613975D1 (de) Dialkyltiacumicine
FI934680A0 (fi) Arylmorfolin, framstaellning och anvaending
DK0604186T3 (da) HIV-proteaseinhibitorer, som er egnede til behandling af AIDS
GR3026428T3 (en) Optical isomers of 7- 3-(1,1-dialkylmethyl-1-amino-1-pyrrolidinyl]-quinolones and naphthyridones as antibacterial agents
DK0561927T3 (da) Farmaceutiske præparater til behandling af maligne B-celle-affektioner
PH22424A (en) (1-arylcyclobutly)-(heterocyclyl)-methylamine compounds useful as therapeutic agents
EA200001029A1 (ru) Производные гигромицина
GR3023757T3 (en) Cyclic benzylamino, benzylamido and benzylimido derivatives as antipsychotic agents.
DK149590C (da) Analogifremgangsmaade til fremstilling af 2-aryl-3,4-diaza-bicyclo(4,1,0)hepten-(2)-on-(5)-forbindelser
JPS5695116A (en) Xanthine oxidase inhibitor and therapeutic treatment thereby
EA200200292A1 (ru) Производные гигромицина
EA200001028A1 (ru) Производные 2"-деоксигигромицина
JPS57108083A (en) 5-phenyltetrazole compound
MA19966A1 (fr) Nouveaux derives de la pyrrolidine et leur preparation
DK0488044T3 (da) En imidazobenzodiazepin til behandling af søvnforstyrrelser
BG50776A1 (en) Derivatives of n- (2- phenylmorpholinomethyl)- succinamide and method for their preparation